This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Financing, Structuring & Investing in Litigation Finance
June 3rd, 2025
The Union League Club New York CityNew York, NY

Adam Rosen
Managing Director at Rocade Capital
Speaker

Profile

Adam Rosen serves as the Managing Director of Underwriting for Rocade Capital LLC and is responsible for collateral valuation, litigation monitoring, and strategic guidance. Adam is an experienced litigator who represented plaintiffs across the country in complex and mass tort cases involving medical device, pharmaceutical, and consumer products liability. Adam began his career clerking in federal and state court trial courts, where he helped adjudicate complex and high-value disputes. He then went into private practice at a well-known mass tort firm and worked under lead counsel to advance multidistrict litigation to bellwether trials by developing expert witnesses and passing dispositive Daubert motions. His practice covered a range of multidistrict and complex litigations including Talcum Powder, Transvaginal Mesh, Actos, Granuflo, 3M Combat Arms Earplugs, Children’s Tylenol, Elmiron, Medtronic Insulin Pumps, Xarelto, Paragard, Zantac, and Heparin. Adam received his A.B. in Government from the College of William & Mary and his J.D. from Case Western Reserve University School of Law. Adam also studied jurisprudence during law school as a visiting student at Magdalen College, University of Oxford. Adam is a member in good standing of both the Pennsylvania and District of Columbia Bar.

Agenda Sessions

  • Can the Growth of the Mass Tort Market Continue?

    2:55pm